Dayspa

JAN 2018

DAYSPA is the business resource for spa & wellness professionals! Each issue covers the latest in skin care, spa treatments, wellness services and management strategies.

Issue link: https://dayspamagazine.epubxp.com/i/918922

Contents of this Issue

Navigation

Page 29 of 83

[ 28 ] • # dayspamagazine • january 2018 D escribing the activities and eff ects of topical skincare products once they make contact with the skin can be challenging for manufacturers and practitioners. After all, with the exception of most sunscreens, which are purposefully formulated to remain on the skin's surface, consumers are looking for products that can penetrate and do something. Thus, the imperative that has kept manufacturers' R&D; experts extremely busy over the past 20 years is the development of eff ective delivery systems: methods by which certain key ingredients are able to gain access to the skin's deeper layers to eff ect change. "Eff ecting change" is where the tricky part comes in. Although the U.S. Food and Drug Administration (FDA) doesn't currently regulate the manufacture of cosmetic products, it does strictly diff erentiate them from drugs (which the agency, of course, does regulate) by laying out specifi c defi nitions for each category based on the intended use. Per the FDA, cosmetics are intended to beautify or promote attractiveness, and drugs are intended to aff ect the structure or function of the body—and that includes the skin. Therefore, if a product marketed as a cosmetic is shown—or purported—to actually alter the skin's inner structures or functions, it's crossing over into drug territory and is subject to a completely diff erent set of legal criteria. © GETTY IMAGES Experts discuss what's new and noteworthy in topical delivery systems. by Linda Kossoff Safe Passage

Articles in this issue

Archives of this issue

view archives of Dayspa - JAN 2018